Jinling Pharmaceutical Company Limited (SZSE: 000919)
Health Care · Pharmaceuticals · CN
CN¥6.67
+2.62% today · -3.5% 1Y
Jinling Pharmaceutical Company Limited (SZSE: 000919) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $619.32M and employs 5,716 people.
Over the last twelve months the share price has lost 3.5%, trading between 5.67 and 9.80.
Tweenvest scores Jinling Pharmaceutical Company Limited across four factors: quality 72/100, value 52/100, growth 0/100, dividend 35/100. Its strongest factor is quality.
000919 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $619.32M
- Revenue (TTM)
- $468.24M
- P/E
- 74.11
- EPS
- 0.09
- Dividend yield
- 1.50%
- Beta (5Y)
- 0.23
- 52-week high
- CN¥9.80
- 52-week low
- CN¥5.67
- Avg volume (3M)
- —
- Shares outstanding
- 621.92M
- Employees
- 5,716
- Next earnings
- —
About Jinling Pharmaceutical Company Limited
Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in the manufacture and distribution of a diverse range of pharmaceutical products. Its key offerings include the Mailuoning injection, prescribed for the management of numerous vascular and thrombotic conditions such as thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and its sequelae, multiple forms of arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, and thrombophlebitis. The company also provides ferrous succinate tablets for the prevention and treatment of iron deficiency anemia, alongside lentinan injection used in the therapy of malignant tumors. Furthermore, Jinling Pharmaceutical offers medical health care services. The firm's operations are primarily based in Nanjing, China.
- ISIN
- CNE0000010W5
- Founded
- 1998
- Listed since
- Nov 18, 1999
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Wuhan Hvsen Biotechnology Co.,Ltd.SZSE: 300871 | $625.65M | CN¥20.91 | -0.90% |
| Henan Taloph Pharmaceutical Stock Co.,LtdSHSE: 600222 | $625.37M | CN¥7.78 | -1.39% |
| Shanghai New World Co., LtdSHSE: 600628 | $623.88M | CN¥6.46 | +1.57% |
| Sun Pharma Advanced Research Company LimitedNSEI: SPARC | $622.35M | Rs185.60 | -1.14% |
| Zhuhai Rundu Pharmaceutical Co., Ltd.SZSE: 002923 | $612.48M | CN¥12.25 | +11.06% |
| Komipharm International Co., Ltd.KOSDAQ: A041960 | $611.29M | ₩11,360.00 | +14.98% |
| Harbin Medisan Pharmaceutical Co., Ltd.SZSE: 002900 | $609.75M | CN¥12.91 | -0.46% |
| IOL Chemicals and Pharmaceuticals LimitedBSE: 524164 | $609.16M | Rs200.85 | -4.11% |
Figures last refreshed Oct 11, 2026.